Opioid Analgesics after Bariatric Surgery: A Scoping Review to Evaluate Physiological Risk Factors for Opioid-Related Harm
Journal of Clinical Medicine · 27.06.2023 · 12 (13) · 4296
DOI: 10.3390/jcm12134296 ↗Kurz gefasst
Scoping Review in der Zeitschrift Journal of Clinical Medicine, online erschienen am 27.06.2023. Verfasst von Stephanie C M Wuyts und 3 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy Department, Universitair Ziekenhuis Brussel (UZ Brussel), 1090 Brussels, Belgium. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The persisting use of opioids following bariatric surgery has emerged as a prevalent complication, heightening the probability of opioid-related harm (ORM), such as opioid-related fatalities and prescription opioid use disorder (OUD). A comprehensive review of PubMed literature from 1990 to 2023 was conducted to pinpoint physiological influences on postoperative ORM. As a result, we found that patients undertaking bariatric operations often exhibit an inherently higher risk for substance use disorders, likely attributable to genetic predisposition and related neurobiological changes that engender obesity and addiction-like tendencies. Furthermore, chronic pain is a common post-bariatric surgery complaint, and the surgical type impacts opioid needs, with increased long-term opioid use after surgeries. Additionally, the subjective nature of pain perception in patients with obesity can distort pain reporting and the corresponding opioid prescription both before and after surgery. Furthermore, the postoperative alterations to the gastrointestinal structure can affect the microbiome and opioid absorption rates, resulting in fluctuating systemic exposure to orally ingested opioids. The prospect of ORM development post-bariatric surgery appears amplified due to a preexisting susceptibility to addictive habits, surgically induced pain, modified gut–brain interaction and pain management and the changed pharmacokinetics post-surgery. Further research is warranted to clarify these potential risk variables for ORM, specifically OUD, in the bariatric population.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pharmacy Department, Universitair Ziekenhuis Brussel (UZ Brussel), 1090 Brussels, Belgium.
- Research Group Clinical Pharmacology and Clinical Pharmacy, Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel, 1090 Brussels, Belgium.
- Department of Anesthesiology, Leiden University Medical Center (LUMC), 2333 ZA Leiden, The Netherlands.
- Department of Psychiatry, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.
- Department of Internal Medicine and Pharmacology-Toxicology, Radboud University Nijmegen Medical Center, 6525 GA Nijmegen, The Netherlands.
ORCID-Profile: Stephanie C M Wuyts, Arnt F A Schellekens
Zitieren
APA
Wuyts, S. C. M., Torensma, B., Schellekens, A. F. A., & Kramers, C. K. (2023). Opioid Analgesics after Bariatric Surgery: A Scoping Review to Evaluate Physiological Risk Factors for Opioid-Related Harm. Journal of Clinical Medicine, 12(13), 4296. https://doi.org/10.3390/jcm12134296
Vancouver
Wuyts SCM, Torensma B, Schellekens AFA, Kramers CK. Opioid Analgesics after Bariatric Surgery: A Scoping Review to Evaluate Physiological Risk Factors for Opioid-Related Harm. Journal of Clinical Medicine. 2023;12(13):4296. doi:10.3390/jcm12134296
BibTeX
@article{Wuyts2023,
author = {Wuyts, Stephanie C M and Torensma, Bart and Schellekens, Arnt F A and Kramers, Cornelis Kees},
title = {Opioid Analgesics after Bariatric Surgery: A Scoping Review to Evaluate Physiological Risk Factors for Opioid-Related Harm},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {13},
pages = {4296},
doi = {10.3390/jcm12134296}
}
EUVIMED